In order to quantify Ang II-regulated peptides in relevant urine samples from 11 controls, 17 patients with ADPKD and 9 patients with CKD (Additional file 1: Table S1), we selected three top transitions of each peptide, and ran methods for each sample in duplicates (within-run replicates). This evidence concerns the gene AGT and chronic kidney disease.